...
search icon
akts-img

Aktis Oncology, Inc. Common stock Share Price

AKTS
NSQ
$18.26
+$0.5
(2.82%)
1D

Aktis Oncology, Inc. Common stock Analyst Forecast

Aktis Oncology, Inc. Common stock Share Price Chart

Aktis Oncology, Inc. Common stock Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$979.82M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
36.14K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$16.8 L
$29.16 H
$18.26

About Aktis Oncology, Inc. Common stock, Common Stock

Aktis Oncology, Inc. operates as a clinical-stage oncology company that engages in the development of targeted radiopharmaceutical therapies for cancer treatment. The company offers a miniprotein radioconjugate platform to discover and develop radiopharmaceutical therapies that deliver the tumor-killing properties of radioisotopes. It offers Nectin-4, a miniprotein radioconjugate for the treatment of locally advanced or metastatic urothelial cancer. Its products include AKY-1189 to deliver a radioisotope to Nectin-4 expressing tumors for the treatment of metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and AKY-2519 to deliver radioisotope to B7-H3 CD276 expressing tumors targeting prostate, lung and other solid tumors. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is based in Boston, Massachusetts. more

Aktis Oncology, Inc. Common stock Stock Returns

Data is not properly formatted.

Aktis Oncology, Inc. Common stock Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue1.79M15.35M-27.12M1.49M[{"date":"2020-12-31","value":6.6,"profit":true},{"date":"2021-12-31","value":56.6,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":5.48,"profit":true}]
Cost of Revenue2.41M19.49M-30.24M28.07M[{"date":"2020-12-31","value":7.98,"profit":true},{"date":"2021-12-31","value":64.45,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.84,"profit":true}]
Gross Profit(624.00K)(4.14M)-(3.12M)1.49M[{"date":"2020-12-31","value":-41.96,"profit":false},{"date":"2021-12-31","value":-278.21,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-209.55,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin(34.86%)(26.95%)-(11.49%)100.00%[{"date":"2020-12-31","value":-34.86,"profit":false},{"date":"2021-12-31","value":-26.95,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-11.49,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses31.41M56.42M19.76M34.79M53.54M[{"date":"2020-12-31","value":55.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":35.03,"profit":true},{"date":"2023-12-31","value":61.67,"profit":true},{"date":"2024-12-31","value":94.89,"profit":true}]
Operating Income(32.04M)(60.55M)(19.76M)(34.79M)(52.05M)[{"date":"2020-12-31","value":-3203800000,"profit":false},{"date":"2021-12-31","value":-6055500000,"profit":false},{"date":"2022-12-31","value":-1976400000,"profit":false},{"date":"2023-12-31","value":-3479400000,"profit":false},{"date":"2024-12-31","value":-5205000000,"profit":false}]
Total Non-Operating Income/Expense--3.48M11.53M16.17M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":21.53,"profit":true},{"date":"2023-12-31","value":71.29,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(36.14M)(61.03M)(17.93M)(28.64M)(43.98M)[{"date":"2020-12-31","value":-3614000000,"profit":false},{"date":"2021-12-31","value":-6102700000,"profit":false},{"date":"2022-12-31","value":-1792900000,"profit":false},{"date":"2023-12-31","value":-2864100000,"profit":false},{"date":"2024-12-31","value":-4398000000,"profit":false}]
Income Taxes-(1.83M)-(2.45M)6.00K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-30550,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-40800,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes---(26.19M)(43.99M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-2619300000,"profit":false},{"date":"2024-12-31","value":-4398600000,"profit":false}]
Income From Continuous Operations--(17.93M)(28.64M)(43.98M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1792900000,"profit":false},{"date":"2023-12-31","value":-2864100000,"profit":false},{"date":"2024-12-31","value":-4398000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(40.87M)(59.19M)(17.93M)(28.64M)(43.98M)[{"date":"2020-12-31","value":-4086800000,"profit":false},{"date":"2021-12-31","value":-5919400000,"profit":false},{"date":"2022-12-31","value":-1792900000,"profit":false},{"date":"2023-12-31","value":-2864100000,"profit":false},{"date":"2024-12-31","value":-4398000000,"profit":false}]
EPS (Diluted)(0.66)(0.59)(0.69)(0.66)-[{"date":"2020-12-31","value":-66,"profit":false},{"date":"2021-12-31","value":-59,"profit":false},{"date":"2022-12-31","value":-69,"profit":false},{"date":"2023-12-31","value":-66,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Aktis Oncology, Inc. Common stock Ratios

Aktis Oncology, Inc. Common stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AKTS
Cash Ratio 9.15
Current Ratio 9.27

Aktis Oncology, Inc. Common stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AKTS
ROA (LTM) -14.80%
ROE (LTM) -26.50%

Aktis Oncology, Inc. Common stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AKTS
Debt Ratio Lower is generally better. Negative is bad. 1.47
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.47

Aktis Oncology, Inc. Common stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AKTS
Trailing PE NM
Forward PE NM
P/S (TTM) 201.68
P/B 0.00
Price/FCF NM
EV/R 159.53
EV/Ebitda NM

FAQs

What is Aktis Oncology, Inc. Common stock share price today?

Aktis Oncology, Inc. Common stock (AKTS) share price today is $18.26

Can Indians buy Aktis Oncology, Inc. Common stock shares?

Yes, Indians can buy shares of Aktis Oncology, Inc. Common stock (AKTS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AKTS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aktis Oncology, Inc. Common stock be purchased?

Yes, you can purchase fractional shares of Aktis Oncology, Inc. Common stock (AKTS) via the Vested app. You can start investing in Aktis Oncology, Inc. Common stock (AKTS) with a minimum investment of $1.

How to invest in Aktis Oncology, Inc. Common stock shares from India?

You can invest in shares of Aktis Oncology, Inc. Common stock (AKTS) via Vested in three simple steps:

  • Click on Sign Up or Invest in AKTS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aktis Oncology, Inc. Common stock shares
What is Aktis Oncology, Inc. Common stock 52-week high and low stock price?

The 52-week high price of Aktis Oncology, Inc. Common stock (AKTS) is $29.16. The 52-week low price of Aktis Oncology, Inc. Common stock (AKTS) is $16.8.

What is Aktis Oncology, Inc. Common stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aktis Oncology, Inc. Common stock (AKTS) is

What is Aktis Oncology, Inc. Common stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aktis Oncology, Inc. Common stock (AKTS) is 0.00

What is Aktis Oncology, Inc. Common stock dividend yield?

The dividend yield of Aktis Oncology, Inc. Common stock (AKTS) is 0.00%

What is the Market Cap of Aktis Oncology, Inc. Common stock?

The market capitalization of Aktis Oncology, Inc. Common stock (AKTS) is $979.82M

What is Aktis Oncology, Inc. Common stock's stock symbol?

The stock symbol (or ticker) of Aktis Oncology, Inc. Common stock is AKTS

How Can Investors Use Aktis Oncology, Inc. Common stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Aktis Oncology, Inc. Common stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Aktis Oncology, Inc. Common stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Aktis Oncology, Inc. Common stock shares for Indian investors?

When investing in Aktis Oncology, Inc. Common stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Aktis Oncology, Inc. Common stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Aktis Oncology, Inc. Common stock share price with other stocks in the same sector?

Rather than merely checking the share price of Aktis Oncology, Inc. Common stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Aktis Oncology, Inc. Common stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top